Muscle Biology
11 – 20 of 86
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Potential therapies and biomarkers for LAMA2-CMD. Does the microRNA hype deliver?
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Exploratory Profiling of Urine MicroRNAs in the dy2J/dy2J Mouse Model of LAMA2-CMD : Relation to Disease Progression
(
- Contribution to journal › Article
- 2017
-
Mark
Potent pro-inflammatory and profibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chaindeficient muscular dystrophy
(
- Contribution to journal › Article
-
Mark
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
(
- Contribution to journal › Article
-
Mark
Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
(
- Contribution to journal › Article
- 2016
-
Mark
Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.
(
- Contribution to journal › Article
-
Mark
Skeletal muscle wasting and renewal : a pivotal role of myokine IL-6
(
- Contribution to journal › Scientific review
-
Mark
Update on hereditary colorectal cancer
(
- Contribution to journal › Scientific review
-
Mark
Congenital muscular dystrophy with laminin α2 chain-deficiency. Initiation of disease and development of treatment
2016)(
- Thesis › Doctoral thesis (compilation)
- 2015
-
Mark
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice.
(
- Contribution to journal › Article